TOP STORIES

• REGULATORY Sakigake Status Goes to World’s 1st Renal-Function Improving Agent, BBB-Penetrating Hunter Syndrome Med and 4 More Drugs
  March 28, 2018

• BUSINESS JCR Shooting for Big Chunk of 900 Billion Yen Global Lysosome Storage Disease Market with J-Brain Cargo
  March 27, 2018

• REGULATORY 16 Possible Topics for New Guidelines Including Continuous Manufacturing to Be Discussed at First ICH “Interim Meeting” this Week
  March 26, 2018

• BUSINESS Lilly Japan Sales Up 7% in 2017, Upbeat Biz Fueled by Global Simultaneous Development
  March 23, 2018

• BUSINESS Single Generic Pricing Rule Will Accelerate Unreasonable Price Raises: Sawai Chief
  March 22, 2018

• BUSINESS Toho to Thoroughly Implement Drug Distribution GL, Focus on Cost-Cutting in Response to Impact of Drug Pricing Reform: Pres.
  March 20, 2018

• REGULATORY MHLW Health Policy Chief Questions Volume-Focused Sales Strategies, Urges Drug Makers to Shift to Healthy Lifespan Extension
  March 19, 2018

• BUSINESS Shionogi Nabs Rights to Osaka Upstart’s Tissue Regeneration-Inducing Peptide
  March 16, 2018

• BUSINESS Japan Likely the Only Negative Growth Pharma Market in 2018-2022: IQVIA
  March 16, 2018

• BUSINESS Shionogi’s Single-Dose Flu Med Xofluza Hits Japan Shelves
  March 15, 2018

• BUSINESS Gilead Japan Rolling Up Its Sleeves for Foray into Oncology/Inflammation Market
  March 14, 2018

• TRENDS Merck Deal Could Pave Way for Eisai to Hit 800 Billion Yen Sales Target in FY2020
  March 13, 2018

• BUSINESS Eisai Bags Up-to-US$5.76 Billion Lenvima Alliance with Merck
  March 9, 2018

• BUSINESS Foreign Drug Makers Increased Market Share to Over 60% among Top 20 Makers in 2017
  March 9, 2018

• BUSINESS Torii’s Futhan to Get 43.4% Price Cut in April, Urinorm 24.6%: Top 5 Product Survey
  March 8, 2018

• BUSINESS Mid-Sized Japan Makers to Take Heaviest Hit from April Price Cut, Bigger Peers See Smaller Reductions: Jiho Survey
  March 7, 2018

• REGULATORY Winners and Losers of New PMP Criteria: Januvia Earns 1st Premium while Xarelto, Humira Miss It
  March 6, 2018

• REGULATORY 314 APIs Eligible for Price Maintenance Premium in FY2018, Down from 416
  March 5, 2018

• REGULATORY Opdivo Faces 23.8% Price Cut as Slew of Reduction Rules Apply; Nexium Down 16.1% on Huge Seller Slash
  March 5, 2018

• BUSINESS Japan Ethical Drug Sales Slip 1.0% in 2017, Harvoni Drops Out of Top 10 List: IQVIA
  March 2, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• …
• Next ›
• 最終 »